SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis

Copyright © 2023. Published by Elsevier B.V..

Viral infection-induced cell death has long been considered as a double-edged sword in the inhibition or exacerbation of viral infections. Patients with severe Coronavirus Disease 2019 (COVID-19) are characterized by multiple organ dysfunction syndrome and cytokine storm, which may result from SARS-CoV-2-induced cell death. Previous studies have observed enhanced ROS level and signs of ferroptosis in SARS-CoV-2 infected cells or specimens of patients with COVID-19, but the exact mechanism is not clear yet. Here, we find SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis. SARS-CoV-2 ORF3a promotes the degradation of NRF2 through recruiting Keap1, thereby attenuating cellular resistance to oxidative stress and facilitated cells to ferroptotic cell death. Our study uncovers that SARS-CoV-2 ORF3a functions as a positive regulator of ferroptosis, which might explain SARS-CoV-2-induced damage in multiple organs in COVID-19 patients and imply the potential of ferroptosis inhibition in COVID-19 treatment.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:63

Enthalten in:

Redox biology - 63(2023) vom: 15. Juli, Seite 102752

Sprache:

Englisch

Beteiligte Personen:

Liu, Lihong [VerfasserIn]
Du, Jie [VerfasserIn]
Yang, Sidi [VerfasserIn]
Zheng, Birong [VerfasserIn]
Shen, Jian [VerfasserIn]
Huang, Jiacheng [VerfasserIn]
Cao, Liu [VerfasserIn]
Huang, Siyao [VerfasserIn]
Liu, Xue [VerfasserIn]
Guo, Liping [VerfasserIn]
Li, Chunmei [VerfasserIn]
Ke, Changwen [VerfasserIn]
Peng, Xiaofang [VerfasserIn]
Guo, Deyin [VerfasserIn]
Peng, Hong [VerfasserIn]

Links:

Volltext

Themen:

Ferroptosis
Journal Article
KEAP1 protein, human
Keap1
Kelch-Like ECH-Associated Protein 1
NF-E2-Related Factor 2
NRF2
ORF3a
Research Support, Non-U.S. Gov't
SARS-CoV-2

Anmerkungen:

Date Completed 07.06.2023

Date Revised 15.06.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.redox.2023.102752

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357475054